We are live on
!
Find out more
BIOSU
BioPlus Acquisition Corp. Unit
BIOSU
BIOSU
Delisted
BIOSU was delisted on the 6th of October, 2023.
30 hedge funds and large institutions have $38.8M invested in BioPlus Acquisition Corp. Unit in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
62% less funds holding
Funds holding: 79 → 30 (-49)
82% less capital invested
Capital invested by funds: $220M → $38.8M (-$181M)
96% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 51
Holders
30
Holders Change
-49
Holders Change %
-62.03%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
9
Closed
51
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
SCM
Saba Capital Management
New York
|
-$15M |
| 2 |
HCM
Highbridge Capital Management
New York
|
-$10.8M |
| 3 |
LA
Linden Advisors
New York
|
-$10M |
| 4 |
Goldman Sachs
New York
|
-$8.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$7.5M |
